Offer - Urjas Oil for just ₹ 1 X
Rapilif D 4/0.5 Capsule is a commercial drug that is prescribed in the form of Capsule. Other than this, Rapilif D 4/0.5 Capsule has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Rapilif D 4/0.5 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Rapilif D 4/0.5 Capsule as well, which are listed below. These side effects of Rapilif D 4/0.5 Capsule are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Rapilif D 4/0.5 Capsule is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Rapilif D 4/0.5 Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rapilif D 4/0.5 Capsule related warnings section.
Rapilif D 4/0.5 Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease as it can result in adverse effects. Other contraindications of Rapilif D 4/0.5 Capsule have been discussed in the sections ahead.
Drug reaction of Rapilif D 4/0.5 Capsule with other medicines has been reported. See below for a complete list.
You should also be aware that Rapilif D 4/0.5 Capsule is safe while driving, and is addiction.
Rapilif D 4/0.5 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
Is the use of Rapilif D 4/0.5 Capsule safe for pregnant women?
Rapilif D should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rapilif D 4/0.5 Capsule safe during breastfeeding?
Rapilif D may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rapilif D 4/0.5 Capsule on the Kidneys?
Using Rapilif D does not have any harmful effects on kidneys.
What is the effect of Rapilif D 4/0.5 Capsule on the Liver?
There may be an adverse effect on the liver after taking Rapilif D. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Rapilif D 4/0.5 Capsule on the Heart?
Rapilif D is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Rapilif D 4/0.5 Capsule unless your doctor advises you to do so -
Is this Rapilif D 4/0.5 Capsule habit forming or addictive?
Rapilif D 4/0.5 Capsule does not cause addiction.
Interaction between Food and Rapilif D 4/0.5 Capsule
Due to a lack of research, nothing can be said about the consequences of taking Rapilif D 4/0.5 Capsule together with food.
Interaction between Alcohol and Rapilif D 4/0.5 Capsule
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rapilif D 4/0.5 Capsule.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 476-477
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 303
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avodart® (dutasteride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jalyn (dutasteride and tamsulosin hydrochloride)